Indian pharma: Ecuador to Guatemala, Caplin Point thrived in a low-competition oasis. Now it wants a bigger pie.

In the business of pharmaceuticals, one man’s poison is another’s pill — literally. Even as companies across industries are struggling to make a comeback in the post-pandemic world, Indian pharma companies have been enjoying a dream run on the bourses. Indeed, it’s a great time to be invested in pharma stocks. Sample this: Nearly four out of every five pharma stocks with a market capitalisation of more than INR500 crore are trading above their